Overexpression of a cytosolic hydroxymethylglutaryl-CoA reductase leads to squalene accumulation in yeast.
about
Progress in metabolic engineering of Saccharomyces cerevisiaeVersatile genetic assembly system (VEGAS) to assemble pathways for expression in S. cerevisiaeMetabolic response to iron deficiency in Saccharomyces cerevisiae.Combined metabolic engineering of precursor and co-factor supply to increase α-santalene production by Saccharomyces cerevisiaeProduction of farnesene and santalene by Saccharomyces cerevisiae using fed-batch cultivations with RQ-controlled feed.Combinatorial engineering of mevalonate pathway for improved amorpha-4,11-diene production in budding yeast.Iterative carotenogenic screens identify combinations of yeast gene deletions that enhance sclareol productionAlleviating Redox Imbalance Enhances 7-Dehydrocholesterol Production in Engineered Saccharomyces cerevisiae.In Vivo Validation of In Silico Predicted Metabolic Engineering Strategies in Yeast: Disruption of α-Ketoglutarate Dehydrogenase and Expression of ATP-Citrate Lyase for Terpenoid Production.Combinatorial metabolic pathway assembly in the yeast genome with RNA-guided Cas9.An update on antifungal targets and mechanisms of resistance in Candida albicans.Enhancement of ganoderic acid accumulation by overexpression of an N-terminally truncated 3-hydroxy-3-methylglutaryl coenzyme A reductase gene in the basidiomycete Ganoderma lucidumBiosynthesis of isoprenoids, polyunsaturated fatty acids and flavonoids in Saccharomyces cerevisiae.Metabolic engineering of Escherichia coli for high-specificity production of isoprenol and prenol as next generation of biofuels.Metabolic engineering of oleaginous yeast Yarrowia lipolytica for limonene overproduction.Metabolic engineering of volatile isoprenoids in plants and microbes.Storage lipids of yeasts: a survey of nonpolar lipid metabolism in Saccharomyces cerevisiae, Pichia pastoris, and Yarrowia lipolytica.Developing a yeast cell factory for the production of terpenoids.High-level production of beta-carotene in Saccharomyces cerevisiae by successive transformation with carotenogenic genes from Xanthophyllomyces dendrorhous.Improving the phenotype predictions of a yeast genome-scale metabolic model by incorporating enzymatic constraints.Progress in terpene synthesis strategies through engineering of Saccharomyces cerevisiae.A synthetic biochemistry system for the in vitro production of isoprene from glycolysis intermediates.Enhanced membrane fusion in sterol-enriched vacuoles bypasses the Vrp1p requirement.Overproduction of geranylgeraniol by metabolically engineered Saccharomyces cerevisiae.Effects of acetoacetyl-CoA synthase expression on production of farnesene in Saccharomyces cerevisiae.Shifting the fermentative/oxidative balance in Saccharomyces cerevisiae by transcriptional deregulation of Snf1 via overexpression of the upstream activating kinase Sak1pProduction of squalene by lactose-fermenting yeast Kluyveromyces lactis with reduced squalene epoxidase activity.Effect of lipid particle biogenesis on the subcellular distribution of squalene in the yeast Saccharomyces cerevisiaeIn silico profiling of Escherichia coli and Saccharomyces cerevisiae as terpenoid factories.Coupling gene regulatory patterns to bioprocess conditions to optimize synthetic metabolic modules for improved sesquiterpene production in yeastEnhanced production of a plant monoterpene by overexpression of the 3-hydroxy-3-methylglutaryl coenzyme A reductase catalytic domain in Saccharomyces cerevisiae.Engineering triterpene production in Saccharomyces cerevisiae-beta-amyrin synthase from Artemisia annua.Influence of squalene on lipid particle/droplet and membrane organization in the yeast Saccharomyces cerevisiae.Enhancing beta-carotene production in Saccharomyces cerevisiae by metabolic engineering.Construction of a controllable β-carotene biosynthetic pathway by decentralized assembly strategy in Saccharomyces cerevisiae.In vitro reconstitution guide for targeted synthetic metabolism of chemicals, nutraceuticals and drug precursors.Production of isoprenoid pharmaceuticals by engineered microbes.Squalene epoxidase as a target for manipulation of squalene levels in the yeast Saccharomyces cerevisiae.Engineering yeast metabolism for production of terpenoids for use as perfume ingredients, pharmaceuticals and biofuels.Cloning and characterization of the Yarrowia lipolytica squalene synthase (SQS1) gene and functional complementation of the Saccharomyces cerevisiae erg9 mutation.
P2860
Q28757069-BC25C7ED-935E-4969-AD11-3D8A70D77319Q30371791-589C64E1-E0C6-43A4-8F0F-D9907108FBFBQ33824987-5A93FAE6-77A9-49C6-BFCD-828BBA4A2FE5Q34296949-8A686073-162A-4C4F-BBA5-F1BF07FA6257Q34482213-E3A06BB3-CC90-4DB8-97B5-8A2547C8D06AQ35016516-A541706C-413D-402B-96E6-6D3EF30C9401Q35549894-69C7F734-58B4-4FFF-BDD8-5D7F6D8888D6Q35670317-1715D452-9EBD-421E-9C9B-B0F561A42548Q35877958-D30BCDC5-D7DC-4E79-8B60-FC4A48717DD3Q36006378-28C8A55C-15E9-49F4-A764-159D0C482CA3Q36235037-F332074D-E61D-4E46-B499-C022B8891D5DQ36362514-01A6F082-FFA2-41D3-861B-D3253F503028Q36486367-4D466799-45EA-45BA-9570-3FE5520D9B12Q36846947-243D63B3-ECD2-4821-B9C4-5E93B3E26F63Q37326313-720C5A11-1B6A-47E3-8CA1-3ACEEC8A30F2Q38192718-01F6012B-4939-4D9B-93A3-0F477D35E3B0Q38193591-28B276AE-B759-4BF5-AADD-35362EFEECFDQ38201027-13336443-B863-45CA-83A6-B3236453CA52Q38301844-C413433E-D2FF-452E-81F9-3DF4ABFC21C5Q38639782-60FFDD37-8813-4AE7-83D3-87368BF13DA9Q38828293-47AB6BA0-F61F-4F58-A52A-6F7C1B3A7480Q39095485-EBE0FB8B-B2CD-4A4B-80D3-B67662469C0DQ40070000-D7177601-F995-44C4-ADFA-018E3D79814DQ41894142-F9D50743-8BE4-48C2-A516-EA6A925839B6Q42026549-923746E7-A29D-40DC-9241-C68A7445FDEEQ42120525-B6563F5E-7C6A-42DB-8C1E-D6CC7CF14BF8Q42149328-5F001BF3-028E-485A-87D7-106DF369837AQ42152873-7F633FCB-D941-4506-A6A1-5EA1144694E1Q42275167-A9FB29EB-AC63-4F63-AF82-E9DCD5891AC5Q42320430-B38A5D54-ADCF-4CF0-90E9-438EA2A44D17Q42413679-42A5568E-BE5F-4BA8-B6D5-BD45A376B77DQ42648117-560C80EC-C4FF-4F10-9E6F-954735A34AEEQ42956767-875F0D52-6A19-4654-AC04-155A127D3D22Q44359030-9AB4A116-8E06-4CF8-8611-AAE4A8E0A784Q44842587-938CB7E8-825A-4539-A28A-E62282ECD21FQ45981589-903F85FF-17B4-4DC7-AF8A-C4C595EBB5A1Q46052551-EB6A7A10-8458-48D3-A06C-96D0A1E4EE4EQ46671968-FA6D0B31-4D0F-44F7-BC06-CBECFF34A49EQ47387877-278AC89F-591D-4298-951E-5CC24EB7374FQ47889782-7494AD58-50E7-4F88-B289-134B12C1A9F8
P2860
Overexpression of a cytosolic hydroxymethylglutaryl-CoA reductase leads to squalene accumulation in yeast.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Overexpression of a cytosolic ...... qualene accumulation in yeast.
@en
Overexpression of a cytosolic ...... qualene accumulation in yeast.
@nl
type
label
Overexpression of a cytosolic ...... qualene accumulation in yeast.
@en
Overexpression of a cytosolic ...... qualene accumulation in yeast.
@nl
prefLabel
Overexpression of a cytosolic ...... qualene accumulation in yeast.
@en
Overexpression of a cytosolic ...... qualene accumulation in yeast.
@nl
P2093
P356
P1476
Overexpression of a cytosolic ...... qualene accumulation in yeast.
@en
P2093
P2888
P356
10.1007/S002530051138
P407
P577
1998-01-01T00:00:00Z